Eventide Asset Management’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-208
Closed -$3.5M 117
2019
Q1
$3.5M Buy
+208
New +$3.5M 0.12% 94